Wegovy before and after 4 months: what to realistically expect

Month four in real terms: where most people find themselves

Picture this: you ordered Wegovy on a Monday in January, your consultation was reviewed that afternoon, and the pen arrived Tuesday morning. By early May (four months later) you have been through the 0.25mg starter, moved through 0.5mg and 1.0mg, and are likely now on 1.7mg or approaching it. That titration timeline matters because the therapeutic effect of semaglutide accumulates with each dose step.

At this stage, appetite suppression is usually well established. Many people describe meals that used to feel routine now feeling complete at roughly half the portion. Cravings (particularly for calorie-dense foods) tend to quieten. That shift is the mechanism working: semaglutide activates GLP-1 receptors involved in both satiety signalling and the rate at which the stomach empties, meaning fullness arrives sooner and stays longer. The full overview of how Wegovy works covers the pharmacology in more detail.

Weight loss in month four is still building rather than plateauing for most people. The STEP 1 trial data (the landmark 68-week study whose findings are summarised on the NHS semaglutide page) shows the trajectory is steepest in the first six months, with the curve gradually flattening as patients approach and sustain their maintenance dose. Expecting 15% loss at four months would be unrealistic; expecting meaningful, measurable progress is entirely reasonable.

Why results at this point differ so much between individuals

The range of outcomes at four months is genuinely wide. Some people have lost 8% of their starting weight; others are closer to 14%. Several factors shape that spread, and none of them are a verdict on whether the medicine is working.

Dose position is the biggest variable. Someone who tolerated escalation quickly and is already on 1.7mg will typically show faster early progress than someone who spent eight weeks on 0.5mg managing side effects, and that slower approach is clinically sensible, not a failure. Starting weight also matters: someone who began at 110kg will often see a larger absolute loss in kilograms than someone who began at 78kg, even if the percentage is similar.

Lifestyle integration has a measurable effect too. Semaglutide works alongside, not instead of, reduced calorie intake and increased activity, that framing comes directly from the licensed indication. People who have been able to make consistent dietary changes alongside treatment tend to see better results at every checkpoint. If you're curious about what progress can look like as early as the two-month mark, that context helps make sense of where four-month results typically sit. If you're also curious about what the picture looked like at the three-month mark, the comparison helps put four-month data in context.

One thing worth knowing: a week where the scale barely moves is not the same as treatment failure. Hormonal fluctuations, water retention after a heavy training week, or simply the natural variability of how the body sheds fat mass can all produce a temporary plateau. The clinical picture is better read over four-week averages than day-to-day readings.

Side effects at month four: what tends to have settled and what can resurface

For many people, month four is actually more comfortable than months one or two. The worst GI symptoms (nausea, loose stools, indigestion) are most pronounced in the early weeks after each dose increase and typically ease as the body adjusts. By month four, if you have been stable on a dose for several weeks, those effects have often largely quietened.

The exception is a fresh dose step. If month four coincides with moving from 1.0mg to 1.7mg, expect a short window of renewed nausea and digestive sensitivity (usually a week to ten days) before things settle again. This is normal and expected; it is not the treatment becoming less tolerable.

Fatigue and headache are reported by some people in the early months and tend to resolve. The more persistent effects that people sometimes notice at four months are subtler: a changed relationship with alcohol (many find they want less), occasional hair thinning (related to caloric restriction rather than the medicine directly), and for some, a drop in motivation to eat that needs managing to maintain adequate protein intake. The FAQs address several of these practical questions. Any side effect that concerns you should go back to your prescriber, that is exactly what aftercare is for.

Looking beyond four months: the trajectory ahead

The evidence is clear that weight loss with semaglutide continues well past month four for most people on the path to 2.4mg maintenance. The STEP 1 trial's average of around 15% loss was measured at 68 weeks, meaning the work at four months is, in most cases, somewhere between a third and halfway through the active loss phase.

Month six, when many people have been on or near their maintenance dose for several weeks, tends to show another meaningful step. If you want a sense of what that looks like, the six-month picture is worth reading alongside this page. The trajectory after that is more individual: some people continue losing steadily at 2.4mg; others find their weight stabilises and the medicine's role shifts to maintaining that loss. Both are legitimate outcomes.

It is also worth knowing that semaglutide 2.4mg is now available in a higher 7.2mg dose, approved by the MHRA in early 2026, for people with a BMI of 30 or above who are not achieving sufficient response at 2.4mg, though that is a conversation for a prescriber after sustained time on the current maintenance dose, not at month four. The guide to how long Wegovy takes to work puts the full timeline in one place. If you are thinking about cost alongside effectiveness as you plan ahead, the Wegovy pricing page sets out what private treatment typically involves. Starting treatment, or transferring from another provider, begins with a free consultation, check your eligibility with our prescribers and a clinician will review your answers the same day.